Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Myocardial Ischemia Clinical Trial

— IRIDIA  

Official title:

Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00224575
• Other study ID #: AOM03099
• Status: Terminated
• Phase: N/A
• First received: September 13, 2005
• Last updated: March 7, 2016
• Start date: November 2004
• Est. completion date: November 2006

Study information

• Verified date: March 2016
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Description:

not desired

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 260
• Est. completion date: November 2006
• Est. primary completion date: November 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Exclusion Criteria:

• acute myocardial infarction

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Heart Diseases
• Myocardial Ischemia

Intervention

Other:
• diagnosis reassessment
Strategy of diagnosis reassessment following a decision tree.
• Diagnosis strategy and subsequent therapeutic reassessment
Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy

Locations

Country	Name	City	State
France	Hopital Bichat	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly		during hospitalization	No
Secondary	part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months		during hospitalization	Yes